The trademark application KAMBEXTRU was filed by MyoKardia, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 16, 2021, and it was registered by office on September 23, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024.